The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine
So far, no studies have shown that the anti-malarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Science, Spoken · SpokenLayer
June 22, 20208m 50s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
So far, no studies have shown that the anti-malarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks.
Learn about your ad choices: dovetail.prx.org/ad-choices